Breaking News Instant updates and real-time market news.

CLSD

Clearside Biomedical

$5.04

-0.29 (-5.44%)

, ONCE

Spark Therapeutics

$42.62

-3.81 (-8.21%)

08:26
10/25/18
10/25
08:26
10/25/18
08:26

Clearside Biomedical appoints Thomas Ciulla to CMO

Clearside Biomedical (CLSD) announced the appointment of Thomas Ciulla. to the position of CMO. A board certified ophthalmologist and retinal specialist, Ciulla brings over 27 years of clinical practice, academic and executive management experience within the global ophthalmic industry to Clearside. Prior to joining Clearside, Ciulla served as VP, ophthalmic strategy lead at Spark Therapeutics (ONCE).

CLSD

Clearside Biomedical

$5.04

-0.29 (-5.44%)

ONCE

Spark Therapeutics

$42.62

-3.81 (-8.21%)

  • 12

    Nov

CLSD Clearside Biomedical
$5.04

-0.29 (-5.44%)

07/16/18
LDLW
07/16/18
INITIATION
Target $18
LDLW
Buy
Clearside Biomedical initiated with a Buy at Laidlaw
Laidlaw initiated Clearside Biomedical with a Buy and $18 price target.
06/28/18
JANY
06/28/18
INITIATION
JANY
Buy
Clearside Biomedical initiated with a Buy at Janney Montgomery Scott
06/07/18
JMPS
06/07/18
NO CHANGE
Target $25
JMPS
Outperform
Clearside recent Phase 2 DME results being misunderstood, says JMP Securities
JMP Securities analyst Donald Ellis believes that investors are misunderstanding recent Phase 2 diabetic macular edema data reported by Clearside Biomedical, stating that Clearside's data showed that quarterly injections were non-inferior to every 28-day injections and it can be inferred "far superior" than what is seen outside of a controlled clinical trial environment in real-world practice. The analyst, who expects Clearside to conduct a second Phase 2 trial, keeps an Outperform rating and $25 price target on the stock.
05/11/18
WEDB
05/11/18
NO CHANGE
WEDB
Clearside valuation attractive ahead of potential catalysts, says Wedbush
Wedbush analyst Liana Moussatos maintained an Outperform rating and $29 price target on Clearside Biomedical shares, saying the current valuation is attractive in front of multiple potential catalysts, including the Phase 2 TYBEE data for suprachoroidal CLS-TA in DME in Q2, preliminary data from the Phase 3 SAPPHIRE trial for MERVO in Q4, and NDA submission for ME-NIU to the FDA in Q4.
ONCE Spark Therapeutics
$42.62

-3.81 (-8.21%)

10/09/18
GUGG
10/09/18
INITIATION
GUGG
Buy
Spark Therapeutics initiated with a Buy at Guggenheim
Guggenheim analyst Whitney Ijem initiated Spark Therapeutics with a Buy rating and $70 price target. The analyst believes Spark's "in-house manufacturing capabilities and experience can be leveraged across the platform", as well as "provide strategic value as the interest/activity in gene therapy broadens."
08/08/18
08/08/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Aramark (ARMK) downgraded to Neutral from Outperform at Baird with analyst Andrew Wittmann saying the shares rallied following its results, which helped balance the risk/reward. 2. Hostess Brands (TWNK) downgraded to Sector Perform from Outperform at RBC Capital and to Hold from Buy at SunTrust. 3. Spark Therapeutics (ONCE) downgraded to Market Perform from Outperform at BMO Capital with analyst Matthew Luchini saying he believes that the company's latest SPK-8011 hemA data falls short of expectations, with totality of the data suggesting a "less competitive profile versus valrox" and reducing his confidence in the program. 4. Mallinckrodt (MNK) downgraded to Market Perform from Outperform at Raymond James with analyst Elliot WIlbur saying pipeline optionality remains high and is heavily discounted by valuation, and sees no "rational valuation framework" to support further upside. 5. Dentsply Sirona (XRAY) downgraded to Equal Weight from Overweight at Stephens and to Equal Weight from Overweight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/08/18
RHCO
08/08/18
NO CHANGE
Target $61
RHCO
Buy
Spark Therapeutics price target lowered to $61 from $102 at SunTrust
SunTrust analyst Edward Nash lowered his price target on Spark Therapeutics (ONCE) to $61, saying the company's SPK-8011 update has dimmed the outlook for its hemA program. Nash notes that while the FVIII activity reached the 30% threshold set by his physician consultants, it is below that of BioMarin (BMRN) BMN-270, adding the immune risk cannot be eliminated from the treatment. The analyst keeps his Buy rating on Spark Therapeutics, citing expectations of a gradual uptake of its Luxturna in 2018 with modeled commercial opportunity of $322M. Nash adds that Luxturna's commercial success should deepen the company's understanding of hemophilia and help differentiate its products from competitors.
08/08/18
RBCM
08/08/18
NO CHANGE
Target $64
RBCM
Sector Perform
Spark Therapeutics price target lowered to $64 from $75 at RBC Capital
RBC Capital analyst Kennen MacKay lowered his price target on Spark Therapeutics to $64 and kept his Sector Perform rating after its SPK-8011 update indicating lower than expected efficacy and safety profile. The analyst expects the stock to trade "choppy" going into the next round of update on the program at ASH, adding that he is also increasingly concerned about its phase-3 development path.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
05/23/19
05/23
13:17
05/23/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
05/23/19
05/23
13:16
05/23/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TME

Tencent Music

$13.72

-0.335 (-2.38%)

13:15
05/23/19
05/23
13:15
05/23/19
13:15
Options
Tencent put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,135.50

-17.61 (-1.53%)

, GOOG

Alphabet

$1,130.85

-19.65 (-1.71%)

13:13
05/23/19
05/23
13:13
05/23/19
13:13
Hot Stocks
Google announces integration with food delivery service providers »

In a post to a corporate…

GOOGL

Alphabet Class A

$1,135.50

-17.61 (-1.53%)

GOOG

Alphabet

$1,130.85

-19.65 (-1.71%)

UBER

Uber

$40.51

-0.58 (-1.41%)

GRUB

GrubHub

$65.02

-3.52 (-5.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 05

    Jun

  • 19

    Jun

  • 19

    Jun

  • 27

    Jun

  • 27

    Oct

VRNT

Verint

$56.01

-5.2 (-8.50%)

13:11
05/23/19
05/23
13:11
05/23/19
13:11
Hot Stocks
Verint says short seller report 'inaccurate and deliberately misleading' »

Verint Systems issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 20

    Jun

GOOGL

Alphabet Class A

$1,135.74

-17.37 (-1.51%)

, GOOG

Alphabet

$1,130.75

-19.75 (-1.72%)

13:08
05/23/19
05/23
13:08
05/23/19
13:08
Hot Stocks
Google announces integration with food delivery service providers »

In a post to a corporate…

GOOGL

Alphabet Class A

$1,135.74

-17.37 (-1.51%)

GOOG

Alphabet

$1,130.75

-19.75 (-1.72%)

UBER

Uber

$40.50

-0.59 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 27

    Oct

13:08
05/23/19
05/23
13:08
05/23/19
13:08
General news
10-Yr TIPS Auction Coupon Rate data reported »

10-Yr TIPS Auction Coupon…

13:08
05/23/19
05/23
13:08
05/23/19
13:08
General news
10-Yr TIPS Auction Total Amount data reported »

10-Yr TIPS Auction Total…

M

Macy's

$21.36

-0.45 (-2.06%)

13:05
05/23/19
05/23
13:05
05/23/19
13:05
Options
Macy's call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEBK

Wellesley Bancorp

$35.05

(0.00%)

13:02
05/23/19
05/23
13:02
05/23/19
13:02
Hot Stocks
Wellesley Bancorp raises quarterly cash dividend 9.1% to 6c per share »

Wellesley Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JYNT

Joint Corp.

$16.00

-1.5 (-8.57%)

13:02
05/23/19
05/23
13:02
05/23/19
13:02
Recommendations
Joint Corp. analyst commentary at DA Davidson »

Joint Corp. weakness on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 31

    May

AMZN

Amazon.com

$1,812.11

-45.63 (-2.46%)

12:57
05/23/19
05/23
12:57
05/23/19
12:57
Periodicals
Amazon developing wrist device that can read human emotions, Bloomberg says »

Amazon is working on a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 03

    Jun

  • 24

    Jun

JYNT

Joint Corp.

$16.00

-1.5 (-8.57%)

12:56
05/23/19
05/23
12:56
05/23/19
12:56
Periodicals
Joint Corp. mentioned cautiously by Seeking Alpha contributor »

In a short report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 31

    May

ESV

Ensco Rowan

$8.98

-0.87 (-8.83%)

12:55
05/23/19
05/23
12:55
05/23/19
12:55
Options
Ensco put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
05/23/19
05/23
12:55
05/23/19
12:55
Conference/Events
Federal Reserve Bank of Dallas to hold a conference »

Atlanta Federal Reserve…

12:55
05/23/19
05/23
12:55
05/23/19
12:55
Conference/Events
JPMorgan biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Fye,…

INTU

Intuit

$241.77

-5.75 (-2.32%)

12:50
05/23/19
05/23
12:50
05/23/19
12:50
Hot Stocks
Senators ask Intuit about reports of misleading taxpayers on free options »

Senator Elizabeth Warren…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

INTU

Intuit

$241.84

-5.68 (-2.29%)

12:47
05/23/19
05/23
12:47
05/23/19
12:47
Periodicals
TurboTax's 'discount' tricks military into paying to file taxes, ProPublica says »

Intuit, the maker of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

12:45
05/23/19
05/23
12:45
05/23/19
12:45
General news
Breaking General news story  »

San Francisco Federal…

12:45
05/23/19
05/23
12:45
05/23/19
12:45
General news
Breaking General news story  »

Richmond Federal Reserve…

12:45
05/23/19
05/23
12:45
05/23/19
12:45
General news
Breaking General news story  »

Dallas Federal Reserve…

12:45
05/23/19
05/23
12:45
05/23/19
12:45
General news
Breaking General news story  »

Atlanta Federal Reserve…

BCYC

Bicycle Therapeutics

$12.15

(0.00%)

12:44
05/23/19
05/23
12:44
05/23/19
12:44
Syndicate
Bicycle Therapeutics slides after opening at $13.37 »

Bicycle Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

BDX

Becton Dickinson

$232.04

-3.72 (-1.58%)

12:44
05/23/19
05/23
12:44
05/23/19
12:44
Hot Stocks
Becton Dickinson VP Samrat Khichi sells almost $3.8M in company stock »

Becton Dickinson VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHW

Charles Schwab

$42.50

-1.06 (-2.43%)

12:40
05/23/19
05/23
12:40
05/23/19
12:40
Options
Schwab puts active as shares shed 2.6% »

Schwab puts active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.